603983 丸美生物
按盤價 
28.310 -3.140 (-9.984%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.632 | 7.368 | 10.156 | 7.939 | 5.554 |
| 總資產報酬率 ROA (%) | 3.363 | 5.110 | 7.180 | 6.070 | 4.435 |
| 投入資產回報率 ROIC (%) | 3.932 | 5.950 | 8.291 | 6.993 | 5.114 | 邊際利潤分析 |
| 銷售毛利率 (%) | 73.647 | 74.286 | 73.701 | 70.694 | 68.396 |
| 營業利潤率 (%) | 11.022 | 8.574 | 12.827 | 14.348 | 11.973 |
| 息稅前利潤/營業總收入 (%) | 10.717 | 8.030 | 12.344 | 13.601 | 11.199 |
| 淨利潤/營業總收入 (%) | 9.438 | 7.133 | 11.528 | 12.473 | 9.669 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 66.318 | 82.643 | 94.457 | 61.649 | 78.394 |
| 價值變動淨收益/利潤總額(%) | 32.524 | 9.463 | 5.002 | 36.149 | 15.886 |
| 營業外收支淨額/利潤總額(%) | -0.251 | -0.297 | -0.074 | -0.710 | -0.366 | 償債能力分析 |
| 流動比率 (X) | 1.943 | 1.865 | 1.851 | 2.504 | 3.347 |
| 速動比率 (X) | 1.775 | 1.670 | 1.713 | 2.334 | 3.120 |
| 資產負債率 (%) | 25.803 | 26.429 | 31.922 | 23.243 | 20.555 |
| 帶息債務/全部投入資本 (%) | 14.399 | 14.674 | 22.414 | 12.607 | 9.765 |
| 股東權益/帶息債務 (%) | 590.080 | 577.917 | 344.168 | 688.049 | 916.806 |
| 股東權益/負債合計 (%) | 282.885 | 273.207 | 209.176 | 323.331 | 378.829 |
| 利息保障倍數 (X) | -38.645 | -15.485 | -26.085 | -21.034 | -15.332 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 3.479 | 4.253 | 4.425 | 7.911 | 13.222 |
| 存貨周轉天數 (天) | 88.289 | 91.669 | 90.201 | 89.259 | 95.422 |
| 備註： | 即時報價更新時間為 15/09/2026 16:27 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
